期刊文献+

LETP方案治疗中晚期大肠癌96例临床疗效观察

Observation of the clinical efficacy of LFTP regimen in the treatment of 96 advanced colorectal cancer patients
下载PDF
导出
摘要 目的评价LFTP方案治疗中晚期大肠癌的疗效和毒副作用。方法吡喃阿霉素(THP)35 mg/m2,静滴,第1天;顺铂(DDP)20 mg/m2,静滴,第1~5天;亚叶酸钙(LV)200 mg,静滴,第1~5天;氟尿嘧啶(5-Fu)500 mg/m2,静滴6 h,第1~5天;21 d为一个周期。结果96例中CR 7例(7.6%),PR 36例(39.1%),PD 20例(21.8%),总有效率46.7%。本组主要毒副作用为骨髓抑制和口腔黏膜炎,无化疗相关性死亡。结论LFTP方案治疗中晚期大肠癌疗效较好,毒副反应可以耐受,有临床应用价值。 Objective To evaluate the clinical efficacy and the toxicity of the combination chemotherapy(LFTP regimen) with pirarubicin (THP), fluorouracil (5-Fu), leucovorin (LV) and cisplatin (DDP) in the treatment of advanced colorectal cancer. Methods Ninety-six patients with advanced colorectal cancer were treated with LTFP regimen. THP was given iv gtt on the first day at a dose of 35 mg/m^2 , DDP was given iv gtt on the days 1-5 at a dose of 20 mg/m^2, LV was given iv gtt on days 1-5 at a dose of 200 mg/ mE and 5-Fu was given at a dose of 500 mg/m^2 on the days 1-5 by intravenous drip for 6 hours each day. The chemotherapy was repeated every 21 days and a course of treatment included three cycles. Results Seven patients showed complete response (7.6%),36 partial response (39.1%) and 20 had progression of disease (21.8%). The total effective rate was 46.7%. The main toxic effects were myelosuppression and sto- matitis. There was no chemotherapy-related death. Conclusion L^FP regimen is effective and well tolerated in the treatment of advanced colorectal cancer. Therefore, it has significance for clinical therapy.
作者 董虹亮 刘蓉
出处 《中国肿瘤临床与康复》 2007年第3期235-237,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 结直肠肿瘤/化学疗法 吡喃阿霉素 氟尿嘧啶 顺铂 甲酰四氢叶酸 Colorectal neoplasms/chemotherapy Pirarubicin Fluorouracil Cisplatin Leucovorin
  • 相关文献

参考文献3

  • 1Seymour MT,Stenming SP,Cassidy J.Altitudes and practice in the management of metastatic colorectal cancer in Britain.Colorectal Cancer Working Party of the UK Medical Research Council[J].Clin Oncol,1997,9(4):248-251.
  • 2林英城,林雯,林懿.晚期大肠癌化学治疗进展[J].国外医学(肿瘤学分册),2002,29(5):393-396. 被引量:12
  • 3冯奉仪,孙燕.THP-阿霉素[J].北京医学,1992,14(3):177-182. 被引量:50

二级参考文献27

  • 1Carmichael J,Popiela T,Radstone D,et al.Randomized comparative study of ORZEL(R)(oral uracil/tegafur(UFTTM) plus leucovorin(LV))versus parenteral 5-fluorouracil(5-FU)plus LV in patients with metastatic colorectal cancer[J].Proc Am Soc Clin On col,1999,18:264a.
  • 2Van Cutsem E,Sorensen J,Cassidy J,et al.International phase Ⅲ study of oral eniluracil(EU)plus 5-fluorouracil(5-FU)versus intravenous(IV)5-FU plus leucovorin(LV)in the treatment of advanced colorectal cancer(ACC)[J].Proc Am Soc Clin Oncol,2001,20:131a.
  • 3Levin J,Schilsky R,Burris H,et al.North American phase Ⅲ study of oral eniluracil(EU)plus oral 5-fluorouracil(5-FU)versus intravenous(IV)5-FU plus lencovorin(LV)in the treatment of advanced colorectal cancer(ACC)[J].Proc Am Soc Clin Oncol,2001,20:132a.
  • 4Hoff PM,Ausari R,Batist G,et al.Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer:results of a randomized phase Ⅲ study[J].J Clin Oncol,2001,19(8):2282-2292.
  • 5Van Cutsem E,Twelves C,Cassidy J,et al.Oral capecitabine compared with intravenous fluorouracil plus teucovorin in patients with metastatic colorectal cancer:results of a large phase Ⅲ study[J].J Clin Oncol,2001,19(21):4097-4106.
  • 6Meta-Analysis Group in Cancer:Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal eancer[J].J Natl Cancer Inst,1996,88(5):252-258.
  • 7McArdle C,Kerr DJ,Ledermann J,et al.Intravenous(IV)vsintrahepatic arterial(IHA)5-FU/lencovorin for colorectal(CRC)liver metastasis:preliminary results of the mre ero5/eortc 40972 randomized trial[J].Eur J Cancer,2001,37(Suppl 6):257.
  • 8Knight RD,Miller LL,Pirotta N,et al.First-line irinotecan(C),fluorouracil(F),leucovorin(L)especially improves survival(OS) in metastatic colorectal cancer(MCRC)patients(PT)with favorable prognostic indicators[J].Proc Am Soc Clin Oncol,2000,19:255a.
  • 9Maasacesi C,Norman A,Price T,et al.A clinical nomogram for predicting long-term survival in advanced colorectal eancer[J].Eur J Cancer,2000,36(16):2044-2052.
  • 10Bensmaine MA,Marty M,de Gramont A,et al.Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil(5-FU)+/-folinic acid in a compassionate-use cihort of 481 5-FU-resistant advanced colorectal cancer patients[J].Br J Cancer,2001,85(4):509-517.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部